A latest Miami Herald article mentioned the recall of a weight reduction drug discovered to include an unlawful ingredient linked to coronary heart assaults. The one lot of Lipodrene w/25mg Ephedra Extract Dietary Supplement contained DMAA, which is unlawful to market in response to the FDA. DMAA narrows blood vessels and arteries, which will increase blood stress and might trigger cardiovascular issues equivalent to shortness of breath, arrhythmias, and coronary heart assault. Hi-Tech Pharmaceuticals, the producer of the product, issued the recall discover and is investigating the problems.
